EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial

Nadir Yalçın, Merve Kaşıkcı, Hasan Tolga Çelik, Karel Allegaert, Kutay Demirkan, Şule Yiğit

Frontiers in Pharmacology · 14.08.2023 · 14

DOI: 10.3389/fphar.2023.1242779 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.08.2023. Verfasst von Nadir Yalçın und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug-related problems (DRPs) incidence is higher in neonatal intensive care units (NICUs), compared to other pediatric wards due to aspects like off-label medications, pharmacokinetic/dynamic variability, or organ dysfunction/immaturity. This study aimed to determine whether and to what extent a clinical pharmacist intervention improves medication safety and prevents DRPs [medication errors (MEs), adverse drug reactions (ADRs), drug-drug interactions (DDIs)].

Methods

A prospective, randomized, double blind, controlled study in NICU-admitted neonates was conducted. NICU patients were randomly assigned to the intervention (clinical pharmacist-led) (IG) or control group (standard care such as clinical diagnosis, pharmacotherapy) (CG). The clinical pharmacist was involved in the IG to identify-prevent-intervene MEs, or identify and monitor ADRs and DDIs. The primary outcome was the number of neonates who developed at least one DRP compared with those seen across IG and CG. Secondary outcomes included length of hospital stay, total number of drugs or DRP type.

Results

Neonates were randomly assigned to CG (n = 52) or IG (n = 48). In total, 45%, 42%, and 16% of patients had at least 1 MEs, ADRs, and clinically significant DDIs, respectively. The number of patients with at least 1 ME was 28 (53%) and 17 (35%) in the CG and IG ( p >0.05). The median (range) number of ME was higher in CG [1 (0–7)] than in IG [0 (0–4)] ( p = 0.003). Applying regression analysis, the CG had 2.849 times more MEs than the IG ( p <0.001). Furthermore, the number of patients (CG to IG) with at least one detected ADR or clinical DDI was 19 (36%) to 23 (47%) ( p >0.05) and 4 (7%) to 12 (25%), respectively ( p = 0.028).

Conclusion

Clinical pharmacist availability to systematically and standardized identify, prevent and resolve DRPs among NICU patients is effective. Daily detailed clinical pharmacist observations and interventions enables prevention and monitoring of DRPs. Clinical Trial Registration ClinicalTrials.gov , identifier NCT04899960.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionsclinical pharmacist (CP)drug-drug interactions (DDIs)drug-related problems (DRPs)medication errorspharmaceutical carepharmacotherapy optimization

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
  • Department of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
  • Division of Neonatology, Department of Child Health and Diseases, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
  • Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
  • Department of Development and Regeneration, Leuven, Belgium.
  • Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands.

Zitieren

APA

Yalçın, N., Kaşıkcı, M., Çelik, H. T., Allegaert, K., Demirkan, K., & Yiğit, Ş. (2023). Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1242779

Vancouver

Yalçın N, Kaşıkcı M, Çelik HT, Allegaert K, Demirkan K, Yiğit Ş. Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1242779

BibTeX
@article{Yaln2023,
  author = {Yalçın, Nadir and Kaşıkcı, Merve and Çelik, Hasan Tolga and Allegaert, Karel and Demirkan, Kutay and Yiğit, Şule},
  title = {Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1242779}
}
Kostenlos starten →